BioCentury | Oct 3, 2019
Politics & Policy

Experimental GBM vaccine available under U.S. right-to-try program

...ERC is not providing Gliovac under the expanded access pathway, Elliot said. Jonathan Block, Associate Editor Gliovac (ERC1671) ERC Belgium S.A. Right-to-Try expanded...
BioCentury | Jan 11, 2019
Clinical News

Patient receives glioblastoma vaccine under right to try

...Treat recurrent glioblastoma multiforme Endpoint: NA Status: Right to try treatment started Milestone: NA Chris Lieu Gliovac (ERC1671) ERC Belgium S.A. University...
BioCentury | Jan 9, 2019
Clinical News

Patient receives glioblastoma vaccine under right to try

...all of those cells. ERC-USA is a subsidiary of ERC-Belgium S.A. (Les Isnes, Belgium). Chris Lieu Gliovac (ERC1671) ERC Belgium S.A. University...
BioCentury | Jan 27, 2014
Clinical News

Gliovac regulatory update

...The European Commission granted Orphan Drug designation to ERC Belgium's Gliovac to treat glioma. The vaccine consists...
...consists of allogeneic and autologous haptenized and irradiated cells and cell lysates derived from glioma. ERC Belgium...
...trial slated to start this year. The product has Orphan Drug designation in the U.S. ERC Belgium S.A....
Items per page:
1 - 4 of 4
BioCentury | Oct 3, 2019
Politics & Policy

Experimental GBM vaccine available under U.S. right-to-try program

...ERC is not providing Gliovac under the expanded access pathway, Elliot said. Jonathan Block, Associate Editor Gliovac (ERC1671) ERC Belgium S.A. Right-to-Try expanded...
BioCentury | Jan 11, 2019
Clinical News

Patient receives glioblastoma vaccine under right to try

...Treat recurrent glioblastoma multiforme Endpoint: NA Status: Right to try treatment started Milestone: NA Chris Lieu Gliovac (ERC1671) ERC Belgium S.A. University...
BioCentury | Jan 9, 2019
Clinical News

Patient receives glioblastoma vaccine under right to try

...all of those cells. ERC-USA is a subsidiary of ERC-Belgium S.A. (Les Isnes, Belgium). Chris Lieu Gliovac (ERC1671) ERC Belgium S.A. University...
BioCentury | Jan 27, 2014
Clinical News

Gliovac regulatory update

...The European Commission granted Orphan Drug designation to ERC Belgium's Gliovac to treat glioma. The vaccine consists...
...consists of allogeneic and autologous haptenized and irradiated cells and cell lysates derived from glioma. ERC Belgium...
...trial slated to start this year. The product has Orphan Drug designation in the U.S. ERC Belgium S.A....
Items per page:
1 - 4 of 4